Morange
Marseille, 13005, France
NCT Number: NCT01354327
The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Marseille, 13005, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
3 tablets / day during 4 months
3 tablets / day during 4 months
Time frame: 4 months
Time frame: 4 months
Lescuyer Laboratory
Industry
Study of the Effects of Limicol (a Food Supplement) on LDL-cholesterol in Moderate Hypercholesterolemia Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00408382
Arterial Occlusive Diseases, Arteriosclerosis
Osaka, Japan
View Trial DetailsNCT03634436
Dyslipidemias, Hypercholesteremia
Beijing, Beijing Municipality, China
View Trial DetailsNCT05164185
Dyslipidemias, Endothelial Dysfunction
Stockholm, Sweden
View Trial DetailsNCT02850224
Blood Pressure, Body Weight
Detroit, Michigan, United States
View Trial Details